SCHEMBL7945235

SCHEMBL7945235

Cc1cc(Oc2ncc(C(F)(F)F)cc2Cl)ccc1C=O

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.55
SMN1; SMN2 Q16637 6/20 0.54
LMNA P02545 7/20 0.54
ALDH1A1 P00352 3/20 0.53
HTT P42858 3/20 0.53
MAPT P10636 2/20 0.53
POLB P06746 1/20 0.53
LIPE Q05469 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C19 P33261 1/20 0.50
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
XBP1 P17861 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
HPGD P15428 3/20 0.49
FFAR1 O14842 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7935274 0.87 LMNA (0.55) RAB9ASMN1; SMN2LMNAALDH1A1HTT
SCHEMBL9572436 0.86 RAB9A (0.65) RAB9ASMN1; SMN2LMNAALDH1A1HTT
SCHEMBL16638538 0.85 RAB9A (0.62) RAB9ASMN1; SMN2LMNAALDH1A1HTT
SCHEMBL11262678 0.81 CYP1A2 (0.63) RAB9ASMN1; SMN2LMNAALDH1A1HTT
SCHEMBL11299037 0.81 RAB9A (0.65) RAB9ASMN1; SMN2LMNAALDH1A1HTT
SCHEMBL7945622 0.81 SMN1; SMN2 (0.62) RAB9ASMN1; SMN2LMNAALDH1A1HTT
SCHEMBL11360493 0.80 SMN1; SMN2 (0.71) RAB9ASMN1; SMN2LMNAALDH1A1HTT
SCHEMBL1153779 0.80 LMNA (0.61) RAB9ASMN1; SMN2LMNAALDH1A1HTT
SCHEMBL7941573 0.80 RAB9A (0.59) RAB9ASMN1; SMN2LMNAALDH1A1HTT
SCHEMBL12585076 0.79 LMNA (0.64) RAB9ASMN1; SMN2LMNAALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010015653-A1 PYRIMIDINE DERIVATIVES AS ACTIVATORS OF SOLUBLE GUANYLATE CYCLASE SMITHKLINE BEECHAM CORPORATION (US) 2010-02-11 WO disclosed